Form 4 for CRL Charles River Laboratories
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-05 · accession 0001127602-25-017074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-09 | 2025-06-05 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -385 | 25.3K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-05 | G | D | 385 | $0.00 | 25,316 | D | — | — |